Document Detail


Is the left atrial appendage more than a simple appendage?
MedLine Citation:
PMID:  19360867     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The left atrial appendage (LAA) is a cardiac structure with unique anatomic and functional features. It is significantly more than a simple chamber appended to the left atrium (LA), differing from the LA in structure, function, and hormonal activity. Unfortunately, it is the source of more than 90% of cardiac-based emboli, particularly in atrial fibrillation, mandating lifelong anticoagulation. Percutaneous LAA exclusion was developed to limit or eliminate cardioembolic events in patients with atrial fibrillation. Benign healing of the appendage occurs without adverse hemodynamic effects, and with no residual surface thrombus or tissue damage. The feasibility of this treatment is now established, suggesting that percutaneous therapy is safe, practical and possibly effective to eliminate the need for anticoagulation and significantly reduce cardioembolic events.
Authors:
Hidehiko Hara; Renu Virmani; David R Holmes; Maurice Buchbinder; John R Lesser; Robert A Van Tassel; Michael R Mooney; Robert S Schwartz
Related Documents :
1514497 - Comparison of cardiac dimensions by transesophageal and transthoracic echocardiography.
6450017 - Visualization of atrial myocardium with tl-201: case report.
6297827 - Comparative studies of atrial and ventricular myosin from normal, thyrotoxic, and thyro...
11228857 - Bipolar atrial sensing thresholds in sinus rhythm and atrial tachyarrhythmias. a compar...
11792327 - Comparison of direct stenting versus stenting with predilation for the treatment of sel...
10455837 - A case of ventricular fibrillation in the prone position during back stabilisation surg...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  74     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-04     Completed Date:  2009-10-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  234-42     Citation Subset:  IM    
Copyright Information:
(c) 2009 Wiley-Liss, Inc.
Affiliation:
Minneapolis Heart Institute and Foundation, Minneapolis, Minnesota, USA. harahide@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anticoagulants / adverse effects,  therapeutic use*
Atrial Appendage / pathology,  physiopathology,  surgery*
Atrial Fibrillation / complications,  pathology,  physiopathology,  therapy*
Cardiac Surgical Procedures* / adverse effects
Embolism / etiology,  prevention & control*
Female
Heart Catheterization / adverse effects,  methods*
Hemodynamics
Humans
Male
Middle Aged
Risk Assessment
Risk Factors
Treatment Outcome
Wound Healing
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Percutaneous versus surgical revascularization for multivessel coronary artery disease: a single cen...
Next Document:  The incidence and predictors of postprocedural incomplete stent apposition after angiographically su...